Literature DB >> 10454383

Cancer survival in Britain is poorer than that of her comparable European neighbours.

K Sikora.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10454383      PMCID： PMC1116372          DOI： 10.1136/bmj.319.7208.461

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  1 in total

1.  Influence of clinician workload and patterns of treatment on survival from breast cancer.

Authors:  R Sainsbury; B Haward; L Rider; C Johnston; C Round
Journal:  Lancet       Date:  1995-05-20       Impact factor: 79.321
  1 in total
  7 in total

1.  Cancer survival in Britain. Cancer chemotherapy costs money.

Authors:  P G de Takats
Journal:  BMJ       Date:  1999-12-11

2.  Improving cancer outcomes through radiotherapy. Lack of UK radiotherapy resources prejudices cancer outcomes.

Authors:  N G Burnet; R J Benson; M V Williams; J H Peacock
Journal:  BMJ       Date:  2000-01-22

3.  Lack of funding will inhibit evidence based commissioning of cancer treatments.

Authors:  J So; J H Scarffe; E Rous; R Foy
Journal:  BMJ       Date:  2000-01-01

4.  New arrangements for NHS R&D funding: implications for primary care research.

Authors:  Roger Jones; Yvonne Carter; Sean Hilton
Journal:  Br J Gen Pract       Date:  2002-01       Impact factor: 5.386

5.  Cancer recognition and primary care.

Authors:  Nicholas Summerton
Journal:  Br J Gen Pract       Date:  2002-01       Impact factor: 5.386

6.  Should NHS patients be allowed to contribute extra money to their care?

Authors:  C Richards; R Dingwall; A Watson
Journal:  BMJ       Date:  2001-09-08

7.  What if cancer survival in Britain were the same as in Europe: how many deaths are avoidable?

Authors:  M Abdel-Rahman; D Stockton; B Rachet; T Hakulinen; M P Coleman
Journal:  Br J Cancer       Date:  2009-12-03       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.